(Fast Consumer Products News) On November 4, China's second largest professional skin care product company, Gizi Bio (02367.HK), was listed on the main board of the Hong Kong Stock Exchange. As of May 31, 2022, the company's net profit was 314 million yuan, while the net profit m

(Fast Consumer Products News) On November 4, , China's second largest professional skin care product company, Gizi Bio (02367.HK), was listed on the main board of the Hong Kong Stock Exchange. As of May 31, 2022, the company's net profit was 314 million yuan, while the net profit margin during the same period was 43.4% .

"Fast Consumer Products" It is reported that Xi'an Juzi Biogenetic Technology Co., Ltd. was established in 2001. It is a high-tech enterprise dominated by genetic engineering technology, biomedical materials and tissue engineering, and is also a manufacturer of "human-like collagen" that can be produced worldwide.

In terms of pipeline research, Juzi Bio has established a diversified product pipeline covering professional skin care products, health foods and special medical purpose formula food . At present, Giant Bio has created eight major brands: Kefumei, Kelijin , Pre-prepared, Kefuping, Liyan, Xinri and Shengan, covering effective skin care products, medical dressings and health foods , including a product portfolio of 105 SKUs and a product pipeline of 103 products under development.

In addition, Giant Bio has developed into one of the companies with the largest production capacity of recombinant collagen in the world, with an annual production capacity of 10,880 kg and an industry-leading purification and recovery rate. In the future, Juzi Bio also plans to invest about 1.5 billion yuan to build three new production factories within five years, namely, a factory with production capacity of to 34 million functional skin care products per year, 5 million functional foods and special medical formula foods per year, and 100 million skin rejuvenation products and biomedical materials per year.

Juzi Bio Chairman and CEO Yan Jianya said at the press conference thatJuzi Bio will better leverage its advantages, continue to deepen its synthetic biology field, deepen its entrepreneurship in the recombinant collagen market, be a leader in the recombinant collagen industry, inject strong impetus into the high-quality development of in the industry, and make due contributions to my country's scientific and technological self-improvement and self-reliance.

Image source: Juzi Biology official website